Literature DB >> 19616444

Calcium sensitisation impairs diastolic relaxation in post-ischaemic myocardium: implications for the use of Ca(2+) sensitising inotropes after cardiac surgery.

Yeong-Hoon Choi1, Douglas B Cowan, Thorsten C W Wahlers, Roland Hetzer, Pedro J Del Nido, Christof Stamm.   

Abstract

BACKGROUND: Calcium sensitising inotropes are increasingly being used in cardiac surgical patients. Theoretically, increasing contractile protein sensitivity to Ca(2+) prevents the Ca(2+) elevation associated arrhythmogenicity and potentiates the inotropic effect of catecholamines. On the other hand, we hypothesised that Ca(2+) sensitisation exacerbates post-ischaemic myocardial stunning by impairing diastolic relaxation, which might have deleterious effects in postoperative cardiac surgical patients.
METHODS: In an isolated rabbit heart model, 45 min normothermic ischaemia with potassium-induced cardioplegic arrest was followed by 120 min reperfusion. Isovolumetric left ventricular (LV) function and myocardial oxygen consumption (MvO(2)) were measured, and cytosolic Ca(2+) was monitored by rhod-2 surface spectrofluorometry. During reperfusion, ORG 30029 (250 microM) and levosimendan (0.5 microM) were used as Ca(2+) sensitisers (ORG, n=6, Levo, n=6), Ca(2+) de-sensitisation was induced with butanedione-monoxime (5mM, BDM, n=6), and dopamine (20 nM) served as a representative catecholamine (n=6). To counteract the PDE III inhibiting properties of ORG and Levo, IGF-1 (0.1 microM) and parathyroid hormone (0.05 microM) were used.
RESULTS: As expected, ischaemia/reperfusion induced moderate cytosolic calcium overload. Dopamine increased LV contractility and MvO(2) by augmenting the amplitude of the Ca(2+) transient, but relaxation was unchanged due to faster diastolic Ca(2+) removal. Dopamine-induced Ca(2+) handling was unchanged after uncoupling the Mg-ATPase with BDM, and MvO2 decreased in proportion with the reduced LV mechanical work load. ORG improved contractility without apparent effects on Ca(2+) handling, and MvO(2) remained constant despite increased contractile work. Conversely, ORG induced a rightward shift of the diastolic pressure-volume relationship in post-ischaemic hearts (diastolic pressure at 0.8 ml balloon volume 14.3+/-5 mmHg, p=0.01 vs control), but not in non-ischaemic control hearts. With levosimendan, the Ca(2+) sensitising effects were less pronounced (7.6+/-3 mmHg, p=0.4 vs control). By counteracting the PDE inhibiting effects of ORG and Levo using parathyroid hormone and IGF-1, the negative lusotropic effects of Ca(2+) sensitisation were unmasked.
CONCLUSIONS: Calcium sensitisation improves systolic function and energetic efficiency. However, Ca(2+) sensitisers should be used with caution during post-ischaemic reperfusion, as they may exacerbate myocardial stunning and thus impair cardiac output. Copyright 2009 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19616444      PMCID: PMC4335314          DOI: 10.1016/j.ejcts.2009.05.030

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  22 in total

1.  Rapid protein kinase A--mediated activation of cyclic AMP-phosphodiesterase by parathyroid hormone in UMR-106 osteoblast-like cells.

Authors:  M Ahlström; C Lamberg-Allardt
Journal:  J Bone Miner Res       Date:  1997-02       Impact factor: 6.741

2.  Ca++ sensitizers impair cardiac relaxation in failing human myocardium.

Authors:  R J Hajjar; U Schmidt; P Helm; J K Gwathmey
Journal:  J Pharmacol Exp Ther       Date:  1997-01       Impact factor: 4.030

3.  Rapid endotoxin-induced alterations in myocardial calcium handling: obligatory role of cardiac TNF-alpha.

Authors:  C Stamm; D B Cowan; I Friehs; S Noria; P J del Nido; F X McGowan
Journal:  Anesthesiology       Date:  2001-12       Impact factor: 7.892

4.  Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.

Authors:  I Edes; E Kiss; Y Kitada; F M Powers; J G Papp; E G Kranias; R J Solaro
Journal:  Circ Res       Date:  1995-07       Impact factor: 17.367

5.  Post-ischemic PKC inhibition impairs myocardial calcium handling and increases contractile protein calcium sensitivity.

Authors:  C Stamm; I Friehs; D B Cowan; H Cao-Danh; S Noria; M Munakata; F X McGowan; P J del Nido
Journal:  Cardiovasc Res       Date:  2001-07       Impact factor: 10.787

6.  Preconditioning effects of levosimendan in a rabbit cardiac ischemia-reperfusion model.

Authors:  István Leprán; Piero Pollesello; Szilvia Vajda; András Varró; Julius Gy Papp
Journal:  J Cardiovasc Pharmacol       Date:  2006-10       Impact factor: 3.105

7.  Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.

Authors:  Patricia N Banfor; Lee C Preusser; Thomas J Campbell; Kennan C Marsh; James S Polakowski; Glenn A Reinhart; Bryan F Cox; Ryan M Fryer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-02       Impact factor: 4.733

8.  Dopamine treatment of postischemic contractile dysfunction rapidly induces calcium-dependent pro-apoptotic signaling.

Authors:  Christof Stamm; Ingeborg Friehs; Douglas B Cowan; Hung Cao-Danh; Yeong-Hoon Choi; Lennart F Duebener; Francis X McGowan; Pedro J del Nido
Journal:  Circulation       Date:  2002-09-24       Impact factor: 29.690

9.  Preconditioning with levosimendan prevents contractile dysfunction due to H2O2-induced oxidative stress in human myocardium.

Authors:  Ayşe Saide Sahin; Niyazi Görmüş; Ateş Duman
Journal:  J Cardiovasc Pharmacol       Date:  2007-10       Impact factor: 3.105

10.  Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.

Authors:  Damien Barraud; Valérie Faivre; Thibault Damy; Stéphane Welschbillig; Etienne Gayat; Christophe Heymes; Didier Payen; Ajay M Shah; Alexandre Mebazaa
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  7 in total

1.  New insights on the use of del Nido cardioplegia in the adult cardiac surgery.

Authors:  Paolo Nardi; Calogera Pisano; Fabio Bertoldo; Giovanni Ruvolo
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Myocardial protection using del nido cardioplegia solution in adult reoperative aortic valve surgery.

Authors:  Robert A Sorabella; Hiro Akashi; Halit Yerebakan; Marc Najjar; Ayesha Mannan; Mathew R Williams; Craig R Smith; Isaac George
Journal:  J Card Surg       Date:  2014-05-26       Impact factor: 1.620

3.  The novel cardiac myosin activator omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat.

Authors:  L Nagy; Á Kovács; B Bódi; E T Pásztor; G Á Fülöp; A Tóth; I Édes; Z Papp
Journal:  Br J Pharmacol       Date:  2015-08-04       Impact factor: 8.739

4.  Myocardial cytochrome oxidase activity increases with age and hypoxemia in patients with congenital heart disease.

Authors:  Michael Onwugbufor; Richard J Levy; David Zurakowski; Richard A Jonas; Pranava Sinha
Journal:  Perfusion       Date:  2016-12-05       Impact factor: 1.972

5.  The differential effects of a selective kappa-opioid receptor agonist, U50488, in guinea pig heart tissues.

Authors:  Chi-Feng Hung; Hsin-Ju Li; Hsun-Hao Chang; Gon-Ann Lee; Ming Jai Su
Journal:  Biomed Res Int       Date:  2015-03-01       Impact factor: 3.411

6.  Effect of parathyroid hormone on cardiac function in rats with cardiomyopathy.

Authors:  Gang-Yong Wu; Ting Wu; Bai-Da Xu; Yi-Cheng Shi; Zhi-Yuan Cheng; Xiao Zhang; Xiao Wang; Gang-Jun Zong
Journal:  Exp Ther Med       Date:  2018-07-26       Impact factor: 2.447

7.  Feasibility and safety of continuous retrograde administration of Del Nido cardioplegia: a case series.

Authors:  Marc Najjar; Isaac George; Hirokazu Akashi; Takashi Nishimura; Halit Yerebakan; Linda Mongero; James Beck; Stephen C Hill; Hiroo Takayama; Mathew R Williams
Journal:  J Cardiothorac Surg       Date:  2015-11-26       Impact factor: 1.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.